Lactoferrin Induces Osteoblast Growth through IGF-1R

Area of Science:

• Biochemistry
• Cell Biology
• Molecular Biology

Background:

• Osteoblast growth is crucial for bone health and remodeling.
• Insulin-like Growth Factor-1 (IGF-1) and its receptor (IGF-1R) play significant roles in cellular proliferation and differentiation.
• Lactoferrin, a protein found in milk, has shown potential anabolic effects on bone, but its precise mechanisms are not fully understood.

Purpose of the Study:

• To elucidate the role of the IGF-1 receptor (IGF-1R) in lactoferrin-induced osteoblast proliferation.
• To investigate the signaling pathways, including PI3K and RAS, involved in lactoferrin's effects on osteoblasts.
• To determine the concentration-dependent effects of lactoferrin on osteoblast growth and apoptosis.

Main Methods:

• Osteoblasts were treated with varying concentrations of lactoferrin (0.1–1000 μg/mL) for 5 days.
• Gene and protein expression of IGF-1 and IGF-1R were analyzed using RT-PCR and Western blot.
• Osteoblast proliferation, apoptosis, and levels of phosphorylated PI3K and RAS were assessed in control, lactoferrin-treated, and IGF-1R-silenced groups.

Main Results:

• Lactoferrin significantly upregulated IGF-1 and IGF-1R mRNA and protein expression in a concentration-dependent manner.
• Lactoferrin (100 μg/mL) enhanced osteoblast proliferation and inhibited apoptosis, effects that were diminished with IGF-1R silencing.
• Lactoferrin induced PI3K and RAS phosphorylation, with IGF-1R silencing showing a complex interaction with these pathways.

Conclusions:

• Lactoferrin stimulates osteoblast proliferation and inhibits apoptosis through the IGF-1/IGF-1R signaling pathway.
• Lactoferrin activates PI3K and RAS phosphorylation, potentially via an IGF-1R-independent mechanism.
• These findings highlight lactoferrin as a potential therapeutic agent for bone-related disorders.